Pneumolysin plays a key role at the initial step of establishing pneumococcal nasal colonization

Folia Microbiologica

Volumn 61, Issue 5, 2016, Pages 375-383

  Hotomi, Muneki ^a   Yuasa, Jun ^a   Briles, David E ^b   Yamanaka, Noboru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN; VIRULENCE FACTOR;

ANIMAL; CBA MOUSE; DEFICIENCY; FEMALE; GROWTH, DEVELOPMENT AND AGING; HETEROZYGOTE; METABOLISM; MICROBIOLOGY; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTERIAL PROTEINS; CARRIER STATE; FEMALE; MICE, INBRED CBA; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; VIRULENCE FACTORS;

EID: 84955270636     PISSN: 00155632     EISSN: 18749356     Source Type: Journal    
DOI: 10.1007/s12223-016-0445-z     Document Type: Article

References (47)

1. Berry AM, Paton JC (2000) Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 68:133–140
2. Berry AM, Yother J, Briles DE, Hansman D, Paton JC (1989) Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun 57:2037–2042
3. Boulnois GJ, Paton JC, Mitchell TJ, Andrew PW (1991) Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae. Mol Microbiol 5:2611–2616
4. Briles DE, Nahm M, Schroer K, Davie J, Baker P, Kearney J, Barletta R (1981) Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med 153:694–705
5. Briles DE, Hollingshead SK, Nabors GS, Paton JC, Brooks-Walter A (2000) The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 19(1):S87–S95
6. Briles DE, Novak L, Hotomi M, van Ginkel FW, King J (2005) Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci. Infect Immun 73:6945–6951
7. Brown EJ, Hosea SW, Frank MM (1983) The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream. Rev Infect Dis 5(4):S797–S805
8. Converse GM III, Dillon HC Jr (1977) Epidemiological studies of Streptococcus pneumoniae in infants: methods of isolating pneumococci. J Clin Microbiol 5:293–296
9. Dave S, Carmicle S, Hammerschmidt S, Pangburn MK, McDaniel LS (2004) Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol 173:471–477
10. Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, Tung Y (1997) Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 175:1440–1445
11. Feldman C, Munro NC, Jeffery PK, Mitchell TJ, Andrew PW, Boulnois GJ, Guerreiro D, Rohde JAL, Todd HC, Cole PJ, Wilson R (1991) Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am J Respir Cell Mol Biol 5:416–423
12. Gilley RP, Orihuela CJ (2014) Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization. Front Cell Infect Microbiol 4:163
13. Gray BM, Converse GM III, Dillon HC Jr (1980) Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 142:923–933
14. Gwaltney JM Jr, Sande MA, Austrian R, Hendley JO (1975) Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis 132:62–68
15. Havarstein LS, Coomaraswamy G, Morrison DA (1995) An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc Natl Acad Sci U S A 92:11140–11144
16. Houldsworth S, Andrew PW, Mitchell TJ (1994) Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1/3 by human mononuclear phagocytes. Infect Immun 62:1501–1503
17. Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Bjorck L, Meri S (2002) Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol 168:1886–1894
18. Jedrzejas MJ (2001) Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 65:187–207
19. Kadioglu A, Gingles NA, Grattan K, Kerr A, Mitchell TJ, Andrew PW (2000) Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 68:492–501
20. Kadioglu A, Taylor S, Iannelli F, Pozzi G, Mitchell TJ, Andrew PW (2002) Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect Immun 70:2886–2890
21. Kim JO, Weiser JN (1998) Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis 177:368–377
22. Magee AD, Yother J (2001) Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun 69:3755–3761
23. Marks LR, Mashburn-Warren L, Federle MJ, Hakansson AP (2014) Streptococcus pyogenes biofilm growth in vitro and in vivo and its role in colonization, virulence, and genetic exchange. J Infect Dis 210:25–34
24. Mehr S, Wood N (2012) Streptococcus pneumoniae—a review of carriage, infection, serotype replacement and vaccination. Paediatr Respir Rev 13:258–264
25. Nandoskar M, Ferrante A, Bates EJ, Hurst N, Paton JC (1986) Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin. Immunology 59:515–520
26. Nelson AL, Barasch JM, Bunte RM, Weiser JN (2005) Bacterial colonization of nasal mucosa induces local expression of siderocalin, aniron-sequestering component of innate immunity. Cell Microbiol 7:1404–1417
27. Ogunniyi AD, LeMessurier KS, Graham RM, Watt JM, Briles DE, Stroeher UH, Paton JC (2007) Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infect Immun 75:1843–1851
28. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI (2004) Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190:1661–1669
29. Paton JC (1996) The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae. Trends Microbiol 4:103–106
30. Paton JC, Ferrante A (1983) Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect Immun 41:1212–1216
31. Paton JC, Rowan-Kelly B, Ferrante A (1984) Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 43:1085–1087
32. Perez AC, Pang B, King LB, Tan L, Murrah KA, Reimche JL, Wren JT, Richardson SH, Ghandi U, Swords WE (2014) Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo. Pathog Dis 70:280–288
33. Ratner AJ, Lysenko ES, Paul MN, Weiser JN (2005) Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc Natl Acad Sci U S A 102:3429–3434
34. Rayner CF, Jackson AD, Rutman A, Dewar A, Mitchell TJ, Andrew PW, Cole PJ, Wilson R (1995) Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect Immun 63:442–447
35. Ren B, Szalai AJ, Hollingshead SK, Briles DE (2004) Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun 72:114–122
36. Rubins JB, Duane PG, Charboneau D, Janoff EN (1992) Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect Immun 60:1740–1746
37. Rubins JB, Duane PG, Clawson D, Charboneau D, Young J, Niewoehner DE (1993) Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect Immun 61:1352–1358
38. Rubins JB, Charboneau D, Paton JC, Mitchell TJ, Andrew PW, Janoff EN (1995) Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest 95:142–150
39. Rubins JB, Charboneau D, Fasching C, Berry AM, Paton JC, Alexander JE, Andrew PW, Mitchell TJ, Janoff EN (1996) Distinct roles for pneumolysin’s cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med 153:1339–1346
40. Rubins JB, Paddock AH, Charboneau D, Berry AM, Paton JC, Janoff EN (1998) Pneumolysin in pneumococcal adherence and colonization. Microb Pathog 25:337–342
41. Sanchez CJ, Kumar N, Lizcano A, Shivshankar P, Dunning Hotopp JC, Jorgensen JH, Tettelin H, Orihuela CJ (2011) Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production. PLoS One 6, e28738
42. Shak JR, Ludewick HP, Howery KE, Sakai F, Harvey RM, Paton JC, Klugman KP, Vidal JE (2013) Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms. MBio 10:e00655–13
43. Steinfort C, Wilson R, Mitchell T, Feldman C, Rutman A, Todd H, Sykes D, Walker J, Saunders K, Andrew PW, Boulnois GJ, Cole PJ (1989) Effects of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun 57:2006–2013
44. Weinberger DM, Malley R, Lipsitch M (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378:1962–1973
45. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, Tabeling C, Reppe K, Meixenberger K, Dorhoi A, Ma J, Holmes A, Trendelenburg G, Heimesaat MM, Bereswill S, van der Linden M, Tschopp J, Mitchell TJ, Suttorp N, Opitz B (2011) The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol 187:434–440
46. Yother J, McDaniel LS, Briles DE (1986) Transformation of encapsulated Streptococcus pneumoniae. J Bacteriol 168:1463–1465
47. Yother J, Handsome GL, Briles DE (1992) Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene. J Bacteriol 174:610–618